Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.19 USD | +1.95% | +4.75% | -34.94% |
Financials (USD)
Sales 2024 * | 30.47M | Sales 2025 * | 71.52M | Capitalization | 1.11B |
---|---|---|---|---|---|
Net income 2024 * | -174M | Net income 2025 * | -127M | EV / Sales 2024 * | 14.3 x |
Net cash position 2024 * | 678M | Net cash position 2025 * | 585M | EV / Sales 2025 * | 7.4 x |
P/E ratio 2024 * |
-5.3
x | P/E ratio 2025 * |
-8
x | Employees | 467 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 3.32% |
Latest transcript on Autolus Therapeutics plc
1 day | +1.95% | ||
1 week | +4.75% | ||
Current month | +13.86% | ||
1 month | -23.68% | ||
3 months | -30.51% | ||
6 months | +2.44% | ||
Current year | -34.94% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Pulé
FOU | Founder | 51 | 14-08-31 |
Chief Executive Officer | 59 | 14-09-30 | |
Robert Dolski
DFI | Director of Finance/CFO | 54 | 23-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Berriman
BRD | Director/Board Member | 76 | 14-07-31 |
William Young
BRD | Director/Board Member | 79 | 21-11-14 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 4.19 | +1.95% | 1,948,998 |
24-05-02 | 4.11 | +2.75% | 1,772,139 |
24-05-01 | 4 | +8.70% | 7,722,913 |
24-04-30 | 3.68 | -3.16% | 3,571,963 |
24-04-29 | 3.8 | -5.00% | 5,154,280 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.94% | 1.11B | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- AUTL Stock